Skip to main content

Advertisement

Table 2 Impact of clinicopathological parameters on OS in DLBCL

From: Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma

  Total (n = 71) Number of events P value
Sex    0.219
 Men  Women 38 33 16 10
Extranodal involvement    0.068
 Yes  No 53 18 23 3
Stage    0.520
 I–II  III–IV 18 53 8 18
Elevated LDHb    0.210
 Yes  No 51 17 16 8
B symptomsb    0.149
 Yes  No 20 49 10 15
IPI scoreb    0.431
 0–2  3–5 26 42 8 16
Performance scorea    0.114
 0–2  3–4 62 9 21 5
Responseb    0.061
 CR  PD/PR 51 10 14 5
Age at diagnosis    0.059
 <60 years  ≥60 years 30 41 7 19
Rituximabb    0.782
 Yes  No 59 11 21 4
  1. LDH lactate dehydrogenase, IPI international prognostic index, CR complete response, PD progressive disease, PR partial response
  2. aEastern Cooperative Oncology Group
  3. bData was not available for all patients